A method for constructing a lentiviral recombinant vector for stably overexpressing CX3CL1 in primary chicken intramuscular adipocytes and its application
By constructing the CX3CL1 lentivirus recombinant vector, the problem of low transfection efficiency of primary intramuscular adipocytes in chickens was solved, and the stable overexpression of CX3CL1 was achieved, research efficiency was improved and functional gene molecular markers related to intramuscular fat deposition were obtained. .
Patent Information
- Application Number
- CN202311346481.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-10-18
- Publication Date
- 2024-11-29
- Estimated Expiration
- 2043-10-18
AI Technical Summary
Primary intramuscular fat cells in chickens are difficult to transfect, and the transfection efficiency is low, making it difficult to conduct research on in vitro functional gene identification, especially the relationship between CX3CL1 and fat deposition has not been reported.
CX3CL1 lentivirus recombinant vector was constructed, and the full-length CDS amplification product of the chicken CX3CL1 gene was obtained, and enzyme cleaved and ligated, and transformed into TOP10 competent cells. Then, co-transfected with packaging plasmids to 293T cells for lentivirus packaging and titers. Testing, and finally transfection into intramuscular adipocytes to achieve stable overexpression of CX3CL1.
It significantly improved the transfection efficiency of primary intramuscular adipocytes, increased the probability of the integration of the CX3CL1 gene into the intramuscular adipocyte genome, and quickly constructed a high-level in vitro expression model of CX3CL1, effectively obtained functional genes related to intramuscular fat deposition. Molecular marker.
Smart Images

Figure CN117431272B_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of molecular biology, and in particular to a construction method and application of a CX3CL1 lentiviral recombinant vector stably overexpressed in primary chicken intramuscular adipocytes. Background Art
[0002] Intramuscular fat is an important component of animal muscle. It exists inside muscle fibers and between muscle bundles and is one of the most important indicators for evaluating meat quality. The intramuscular fat content is significantly positively correlated with the tenderness, flavor and juiciness of the muscle, and is closely related to the pH and water-binding capacity of the muscle. Therefore, breeding new broiler breeds / specialized strains with high intramuscular fat content is the goal of modern broiler breeding, and discovering the key functional genes related to intramuscular fat deposition will shorten the generation interval of breeding new broiler breeds / strains with high intramuscular fat.
[0003] Chemokine CX3CL1 is the only member of the CX3C class of chemokines. CX3CL1 is expressed in the testis, brain, heart, and skeletal muscle of mice. CX3CL1 can activate pathways such as MAPK, calmodulin, and tyrosine protein kinase, thereby regulating the proliferation and differentiation of skeletal muscle. In chickens, CX3CL1 is expressed in the breast and leg muscles of chickens from the embryonic stage to the growing stage, but the relationship between CX3CL1 and fat deposition has not been reported. In addition, primary intramuscular adipocytes of chickens are difficult to transfect, and the transfection efficiency is low, which makes it difficult to effectively carry out research on in vitro functional gene identification. Summary of the invention
[0004] In view of the problems existing in the above-mentioned prior art, the present invention provides a construction and application of a lentiviral recombinant vector for stably overexpressing CX3CL1 in primary chicken intramuscular adipocytes.
[0005] First, according to the CDS sequence of the CX3CL1 gene published on Genebank, the target gene was fished out by whole genome synthesis. The CX3CL1 gene and the LV5 vector sequence were further digested, purified and connected, and the connected products were transformed into TOP10 competent cells. The positive clones were sequenced and analyzed. The one with completely correct sequence alignment was the successfully constructed CX3CL1 gene expression plasmid vector. The constructed CX3CL1 recombinant vector plasmid was ultrapurely extracted, the extracted plasmid was packaged, and the packaging plasmid (pGag / Pol, pRev, pVSV-G) and the successfully constructed CX3CL1 gene expression vector plasmid were co-transfected into 293T cells, and the lentivirus was packaged and collected for titer detection. The constructed overexpression CX3CL1 lentiviral expression vector was further transfected into intramuscular adipocytes to detect the expression of CX3CL1 and its effect on intramuscular fat deposition.
[0006] To achieve the above object, the present invention is implemented by the following scheme:
[0007] In a first aspect, the present invention provides a CX3CL1 lentiviral recombinant vector stably overexpressed in chicken primary intramuscular adipocytes, wherein the CX3CL1 lentiviral recombinant vector comprises a chicken CX3CL1 gene, and the vector is a LV5 vector.
[0008] In a second aspect, the present invention provides a method for constructing a lentiviral recombinant vector for stably overexpressing CX3CL1 in primary chicken intramuscular adipocytes, the method being as follows:
[0009] Step 1, obtaining the full-length CDS amplification product of the chicken CX3CL1 gene;
[0010] Step 2, digesting the full-length CDS amplification product of the CX3CL1 gene;
[0011] Step 3, digest the LV5 vector;
[0012] Step 4, purifying the enzyme digestion product obtained in step 2 and the enzyme digestion product obtained in step 3 and then connecting them;
[0013] Step 5, transforming the ligation product obtained in step 4 into TOP10 competent cells, sequencing and analyzing the positive clones, and the one with completely correct sequence alignment is the successfully constructed CX3CL1 gene expression vector plasmid;
[0014] Step 6, ultrapurely extract the constructed CX3CL1 gene expression vector plasmid, package the extracted plasmid, co-transfect the packaging plasmid and the extracted CX3CL1 gene expression vector plasmid into 293T cells, package and collect the lentivirus, and perform titer detection to obtain the CX3CL1 lentiviral recombinant vector.
[0015] Furthermore, the steps of obtaining the full-length CDS amplification product of the chicken CX3CL1 gene in step 1 are as follows:
[0016] Step 1.1, design primers using oligo software according to the CX3CL1 CDS sequence. The CX3CL1 sequence is shown in SEQ ID NO.37. The upstream and downstream primers of the CX3CL1 gene contain NotI and BamHI restriction sites and protective bases at both ends, which are used for subcloning of the vector. The primers are as follows:
[0017]
[0018]
[0019]
[0020] Step 1.2, primers Oligo-1 to Oligo-36 were dissolved in ultrapure water to a concentration of 50 μM, and then the same volume was taken into a 1.5 ml centrifuge tube, mixed evenly, and prepared into oligo mix, and the prepared oligo mix was used for the first round of PCR reaction; the first round of PCR reaction system was: oligo mix: 2 μl, 10×Pfu Buffer (+Mg 2+ ): 3μl, dNTP: 0.6μl, DMSO: 1.2μl, ddH2O: 23μl, Pfu DNA polymerase: 0.2μl; PCR reaction conditions: 95℃3min, 1 cycle; 95℃22sec, 58℃22sec, 72℃40sec, 22 cycles; 72℃5min, 1 cycle;
[0021] Step 1.3, use primers Oligo-1 and Oligo-36 to perform the second round of PCR reaction. The second round of PCR reaction system is: first round PCR product: 1 μl, 10×Pfu Buffer (+Mg 2+ ): 5μl, dNTP: 1μl, DMSO: 2μl, Oligo-1: 1μl, Oligo-36: 1μl, ddH2O: 39μl, Pfu DNA polymerase: 0.3μl; PCR reaction conditions: 95℃3min, 1 cycle; 95℃22sec, 58℃22sec, 72℃40sec, 32 cycles; 72℃5min, 1 cycle; After the PCR reaction, Agarose electrophoresis was used to cut the gel and recover the gene fragments.
[0022] Furthermore, the full-length CDS amplification product of the CX3CL1 gene is digested as described in step 2, specifically as follows: the full-length CDS product of the CX3CL1 gene is digested with NotI and BamHI, and the digestion is carried out at 37°C for 2 hours. The digestion system is 10×Buffer: 5μl, full-length CDS product of the CX3CL1 gene: 42μl, and 1.5μl each of BamHI and NotI.
[0023] Furthermore, the LV5 vector is digested with NotI and BamHI as described in step 3, specifically as follows: the LV5 vector is digested with NotI and BamHI at 37°C for 2 hours, and the digestion system is: 10×Buffer: 5μl, LV5: 5ug, 1.5μl each of BamHI and NotI, and ultrapure water is added to 50μl.
[0024] Furthermore, the digestion product obtained in step 2 and the digestion product obtained in step 3 are purified in step 4 and then connected, specifically as follows: the full-length CDS product of the CX3CL1 gene and the vector LV5 are recovered using a DNA gel recovery kit; the CX3CL1 gene fragment obtained by double digestion and the linearized LV5 vector are connected using T4 DNA ligase, and the connection is carried out at 22° C. for 2 hours. The connection system is: T4 DNA ligase buffer: 2 μl, LV5: 2 μl, full-length CDS product of the CX3CL1 gene: 5 μl, T4 DNA ligase: 1 μl, ddH2O: 10 μl.
[0025] Further, the ligation product obtained in step 4 is transformed into TOP10 competent cells as described in step 5, specifically as follows: 10 μl of the ligation product is added to the centrifuge tube with competent cells, gently mixed, and placed in ice for 30 minutes; the centrifuge tube is placed in a water bath preheated to 42°C, and placed for 90 seconds without shaking the centrifuge tube; the centrifuge tube is quickly transferred to an ice bath to cool the cells for 3 minutes, 800 μl of LB medium without antibiotics is added to each centrifuge tube, and then the centrifuge tube is transferred to a 37°C shaker, 250 rpm, and incubated for 45 minutes to allow the bacteria to recover; 200 μl of the incubated cells are evenly spread on an LB plate containing 50 μg / ml Ampicillin, and after the liquid on the plate is absorbed, the plate is inverted in a 37°C incubator and incubated for 16 hours.
[0026] Furthermore, the packaging plasmids described in step 6 are pGag / Pol, pRev and pVSV-G.
[0027] Furthermore, the packaging plasmid described in step 6 is co-transfected into cells with the extracted CX3CL1 gene expression vector plasmid, and the lentivirus is packaged and collected, and the titer is detected, as follows:
[0028] (1) When 293T cells are 50-60% confluent, the extracted CX3CL1 gene expression vector plasmid and packaging plasmid are transfected into the cells together.
[0029] Take a sterile 5mL centrifuge tube, add 1.5mL serum-free DMEM, 3μL of the extracted CX3CL1 gene expression vector plasmid and packaging plasmid, and mix well; take another sterile 5mL centrifuge tube, add 1.5mL serum-free DMEM, and then add 200μL RNAi-Mate transfection reagent, mix well, and place at room temperature for 5 minutes. Mix the two tubes and place at room temperature for 20-25 minutes to form a transfection mixture; add the transfection mixture to the culture medium and incubate in a 37℃ 5% CO2 incubator for 4-6 hours;
[0030] (2) Aspirate and discard the transfection solution, add 10 mL of DMEM culture medium containing 10% FBS, and continue culturing in a 37°C, 5% CO2 incubator for 72 h;
[0031] (3) Collect the cell supernatant in the culture dish, centrifuge at 4°C, 4000 rpm for 4 min; filter the supernatant after centrifugation with a 0.45 μm filter; ultracentrifuge the filtrate in a centrifuge at 4°C, 20,000 rpm for 2 h; collect the concentrated solution and divide it into 1.5 ml centrifuge tubes and store it in a -80°C refrigerator.
[0032] In a third aspect, the present invention provides the use of the CX3CL1 overexpressing lentiviral recombinant vector in primary chicken intramuscular adipocytes.
[0033] The present invention has the following beneficial effects: by constructing a lentiviral vector for overexpression of CX3CL1, the present invention significantly improves the transfection efficiency of primary intramuscular adipocytes, greatly increases the probability of CX3CL1 gene integration into the genome of intramuscular adipocytes, and rapidly constructs a high-level in vitro expression model of CX3CL1, effectively obtaining molecular markers of functional genes related to intramuscular fat deposition. BRIEF DESCRIPTION OF THE DRAWINGS
[0034] Figure 1 is a sequence comparison chart;
[0035] Figure 2 This is a fluorescence comparison diagram of the CX3CL1 gene lentiviral recombinant vector and the empty vector transfected into intramuscular adipocytes;
[0036] Figure 3 The expression changes of CX3CL1 gene after transfection with CX3CL1 lentiviral recombinant vector, *** indicates p < 0.01;
[0037] Figure 4 Expression of CX3CL1 in the proliferation and differentiation stages of intramuscular adipocytes
[0038] Figure 5 The expression changes of CX3CL1 gene after transfection with CX3CL1 lentiviral recombinant vector. DETAILED DESCRIPTION
[0039] The technical solution of the present invention is further described in detail below in conjunction with the accompanying drawings.
[0040] 1. Construction of CX3CL1 gene expression vector plasmid
[0041] (1) Based on the CX3CL1 CDS sequence published on Genebank (as shown in SEQ ID NO.37) (NM_001077232.2), a total of 1326 bp. Primers were designed using oligo software. The upstream and downstream primers of the CX3CL1 gene contained NotI and BamHI restriction sites and protective bases at both ends for vector subcloning. The primers are shown in Table 1:
[0042] Table 1 CX3CL1 gene oligo primer sequences
[0043]
[0044]
[0045] (2) Dissolve the primers Oligo-1 to Oligo-36 in Table 1 into 50 μM concentration with ultrapure water, and then take the same volume into a 1.5 ml centrifuge tube, mix well, and prepare oligo mix. Use the prepared oligo mix to perform the first round of PCR reaction. The first round of PCR system is as follows: oligo mix: 2 μl, 10×Pfu Buffer (+Mg 2+ ): 3μl, dNTP: 0.6μl, DMSO: 1.2μl, ddH2O: 23μl, Pfu DNA polymerase: 0.2μl. PCR amplification, 95℃3min, 1 cycle, 95℃22sec, 58℃22sec, 72℃40sec, 22 cycles, 72℃5min, 1 cycle.
[0046] (3) Perform the second round of PCR reaction using oligo-1 and oligo-36, and the template is the product of the first round of PCR reaction. The PCR system is as follows:
[0047] First round PCR products 1μl <![CDATA[10×Pfu Buffer(+Mg 2+ )]]> 5μl dNTP 1μl DMSO 2μl Oligo-1 1μl Oligo-36 1μl <![CDATA[ddH2O]]> 39μl Pfu DNA polymerase 0.3μl
[0048] The second round of PCR cycling conditions are as follows:
[0049]
[0050] The first round of PCR can obtain a mixture of non-single-band PCR products mixed with target gene bands. Then, using the first round of PCR products as templates, a single target gene band can be obtained through the second round of PCR. After the PCR reaction is completed, agarose electrophoresis and gel cutting are used to recover the gene fragments.
[0051] (4) The chicken CX3CL1 gene was cloned into the vector LV5 (the LV5 vector was provided by Suzhou Jima Biotechnology Co., Ltd.). The full-length CDS product of the CX3CL1 gene was digested with NotI and BamHI at 37°C for 2 hours. The digestion system was 10×Buffer: 5 μl, full-length CDS product of the CX3CL1 gene: 42 μl, and 1.5 μl each of BamHI and NotI.
[0052] (5) The vector LV5 was digested with NotI and BamHI at 37°C for 2 h. The digestion system was as follows: 10× Buffer: 5 μl, LV5: 5 ug, 1.5 μl each of BamHI and NotI, and ultrapure water to make up to 50 μl.
[0053] (6) Electrophoresis, use DNA gel recovery kit to recover chicken CX3CL1 gene full-length CDS product and vector LV5. Use T4 DNA ligase to connect the chicken CX3CL1 gene fragment obtained by double restriction digestion and the linearized vector, and connect at 22°C for 2 hours. The connection system is as follows: T4 DNA ligase buffer: 2μl, LV5: 2μl, CX3CL1 gene full-length CDS product: 5μl, T4 DNA ligase: 1μl, ddH2O: 10μl.
[0054] (7) Transform the ligation product into competent cells. Competent cells were provided by Suzhou Jima Co., Ltd. Add 10 μl of the ligation product to the competent cells, gently mix the contents, and place in ice for 30 minutes. Place the centrifuge tube in a test tube rack in a water bath preheated to 42°C for 90 seconds without shaking the centrifuge tube. Quickly transfer the centrifuge tube to an ice bath and cool the cells for 3 minutes. Add 800 μl of LB medium without antibiotics to each centrifuge tube, then transfer the centrifuge tube to a 37°C shaker at 250 rpm and incubate for 45 minutes to allow the bacteria to recover. Take 200 μl of the incubated cells and evenly spread them on an LB plate containing 50 μg / ml Ampicillin. After the liquid on the plate is absorbed, place the plate upside down in a 37°C incubator and incubate for 16 hours.
[0055] (8) Pick cloned colonies, extract plasmids and identify them, and pick positive clones. Pick 4 separate, full colonies from the cultured plate and place them in a test tube containing 5 ml (containing 50 μg / ml Ampicillin) LB medium. Place the test tube in a bacterial shaker and culture it at 37°C, 250 rpm for 16 hours. Take 200 μl of the bacterial solution corresponding to the positive clone for sequencing, and store the remaining bacterial solution in glycerol. The sequencing was completed by Suzhou Jima Co., Ltd.
[0056] (9) Compare the sequencing results with the target gene sequence. Figure 1 As shown in Figure 1, the sequence obtained by sequencing is completely consistent with the sequence published on Genebank, indicating that the CX3CL1 gene expression vector plasmid was successfully constructed. The stored glycerol bacterial solution was inoculated with LB culture medium to extract a large amount of plasmids to obtain a sufficient amount of recombinant plasmids. Plasmid extraction was performed using the Tiangen Plasmid Extraction Kit (Tiangen Biochemical, DP104-02). See the partial sequence comparison diagram for Figure 1 .
[0057] 2. Virus packaging and collection
[0058] (1) When the 293T cells are about 60% confluent, the constructed CX3CL1 gene expression vector plasmid and packaging plasmids (pGag / Pol, pRev, pVSV-G) are transfected into the cells.
[0059] The transfection method is as follows: take a sterile 5mL centrifuge tube, add 1.5mL serum-free DMEM, 3μL each of CX3CL1 gene expression vector plasmid and packaging plasmid (pGag / Pol, pRev, pVSV-G), and mix well; take another sterile 5mL centrifuge tube, add 1.5mL serum-free DMEM, and then add 200μL RNAi-Mate transfection reagent, mix well, let it stand at room temperature for 5 minutes, then mix the two tubes and let it stand at room temperature for 20 to 25 minutes to form a transfection mixture.
[0060] Further, the transfection mixture formed above was added to a cell culture medium containing 10% fetal bovine serum, and incubated in a 37°C 5% CO2 incubator for 4 to 6 hours;
[0061] (2) Aspirate and discard the transfection solution, add 10 mL of DMEM culture medium containing 10% FBS, and continue culturing in a 37°C, 5% CO2 incubator for 72 hours.
[0062] (3) Collect the cell supernatant in the culture dish, centrifuge at 4°C, 4000 rpm for 4 min; filter the supernatant after centrifugation with a 0.45 μm filter; ultracentrifuge the filtrate in a centrifuge at 4°C, 20,000 rpm for 2 h; collect the concentrated solution and divide it into 1.5 ml centrifuge tubes and store it in a -80°C refrigerator.
[0063] (4) Virus titer detection: 10 μL of the lentiviral stock solution obtained in step (3) was aspirated and diluted ten-fold into five gradients with 10% FBS DMEM culture medium. 100 μL of the diluted virus solution was added to each well of a 96-well plate cultured with 293T cells. A control group was set up and cultured at 37°C 5% CO2 for 24 h. The diluted virus solution in the 96-well plate was discarded and 100 μL of 10% FBS DMEM culture medium was added to each well. The cells were cultured at 37°C 5% CO2 for 72 h. The virus titer was calculated by fluorescence microscopy based on the dilution multiple, and the titer of the CX3CL1 lentiviral vector was found to be 2*10^8.
[0064] 3. Expression of CX3CL1 gene overexpressing lentiviral recombinant vector in chicken intramuscular adipocytes
[0065] The breast muscle tissue of 3 to 4 high-quality broiler hens that had just hatched was used as the test material. Collagenase I was used for digestion for 1.5 hours, and then 2 volumes of complete culture medium were added to terminate the digestion. The cells were centrifuged at 4000 rpm for 10 minutes, and the supernatant was collected and cultured in a T25 bottle. When the cells were 70% confluent, they were subcultured and inoculated into 24-well plates.
[0066] When the cells are about 50% confluent, transfect the CX3CL1 gene lentiviral recombinant vector. Remove the original culture medium in the culture dish, replace with fresh culture medium, transfect 35ul 2*10^8 titer CX3CL1 gene overexpression lentiviral vector and empty vector respectively, add drop by drop, shake the culture plate gently up and down after adding, and continue to culture at 37℃ 5% CO2. After 24h, remove the virus transfection solution, replace with 10% full culture medium, continue to culture in the incubator for 48h, and observe the fluorescence ( Figure 2 ), which preliminarily indicated that the CX3CL1 gene lentiviral recombinant vector had been successfully transfected into intramuscular adipocytes. Intramuscular adipocytes were further collected and total RNA was extracted. The expression of the CX3CL1 gene after transfection with the CX3CL1 gene lentiviral recombinant vector was detected by Q-PCR technology. The primer sequences of the CX3CL1 gene were F: 5'ATGAGGGTTGCTTCTCTCCAG 3' (SEQ ID NO.38), R: 5'CGACCATTTCTCTTGACGTTG 3' (SEQ ID NO.39). The results are shown in Figure 3 As shown, the expression of CX3CL1 gene was significantly increased after transfection with CX3CL1 gene lentiviral recombinant vector, indicating that the lentiviral recombinant vector model of CX3CL1 gene with stable and high expression in primary chicken intramuscular adipocytes was successfully constructed.
[0067] Q-PCR technology was further used to detect the expression of CX3CL1 gene in the proliferation and differentiation stages of intramuscular adipocytes. Figure 4As shown, the CX3CL1 gene was expressed in both the proliferation and differentiation stages of chicken intramuscular adipocytes, and the expression in the proliferation stage was significantly higher than that in the differentiation stage (p<0.001).
[0068] The CX3CL1 gene lentiviral recombinant vector was further transfected and Oil Red O staining was performed to observe the changes in lipid droplet deposition in primary chicken intramuscular adipocytes 6 days after transfection. Figure 5 As shown, after transfection with CX3CL1 gene lentiviral recombinant vector, lipid droplet deposition in intramuscular adipocytes was significantly reduced (p<0.001).
[0069] The above description is only a preferred embodiment of the present invention, and the protection scope of the present invention is not limited to the above embodiment. Any equivalent modifications or changes made by ordinary technicians in this field based on the contents disclosed by the present invention should be included in the protection scope recorded in the claims.
[0070] SEQ ID NO.37 a tgagggttgc ttctctccag atcccgtttg
[0071] cactgagggt cttgtgcctg gcagctatgg ctggagggca acccagca cctctgaagt
[0072] gttcaaaatg gtgcatctct ttccaccgtg ccatagatca gaggcagata aagagctacc
[0073] gcgagactga accccagtgc accaagaaag ccatcatatt tactactaag aggaacagag
[0074] aaatttgtgc aaatccatat gaaccgtggg tggagaagat cgtgaagaaa ctggaccagg
[0075] aaaaggcctc ggcagcatcc ccacttcccc gggctgacac ttcccctgca gcagcggtgc
[0076] ccaaagagcc tggcatcttc cagaagcaca ccggtctcca agtaccacct tcacctccag
[0077] ccactgctgc cactgcagcg tcagagagag cacccactcc tgctgccagc acagaggcga
[0078] ccagcaaacc cagcccagcc atgcagaacg ccacgcactt ctctgcaggg ccatctgctg
[0079] tgacatcggg agtcgctacg cactctgaag tcgtttcaga agcaaacaga gaatccttaa
[0080] catcggcgca ttcaacagct gatgcagtgg acatggccct cggccagcgc acctcatacc
[0081] ccacagctcc tgcacgtgac tctgacagca aagaagaacc tgcaggatat gctacaagtg
[0082] ctgcgggtga tgtccgaggc acgacttcga cctcaacctc cgaccctgca tccatttcca
[0083] aaggactgga ccatcctagt cttcctacaa acgtccccct ggacacaatc agtgcaagag
[0084] gcagcacatc aggcactgct ttgaggagtt cagctctccc ctccacccca cacatcacag
[0085] aggtcggcat ggtcccatcc acaccgcagg cttctccatc tcctacccaa aaccccacaa
[0086] ctgccataga tgaaggtcct tatgtccatg ccaacaaaaa tttcagttcc tctgcatttg
[0087] gtactgggac attagatcat ttattgccct cgggaaagca aggtcctcta gatatgttag
[0088] ttttcaccag tcagatattc tcagaccaag ccagagcaca ggctacagga agcccaagcc
[0089] acccacctgc actcagctcc ttgtcagggt cccagatgta cttagtcatc cctgtcgccc
[0090] tgataggtgt cctgattgct tgtggtgttg cagccagatg ggcttatgta aaatttgaaa
[0091] tcagaccaga aacaacgtca agagaaatgg tcgaagcctt gctctacctg aaggggac
[0092] accgagacaa cgtctatcca atggaagataa tctgaa
Claims
1. Application of a lentiviral recombinant vector overexpressing chicken CX3CL1 in primary chicken intramuscular adipocytes, It is characterized in that The CX3CL1 lentiviral recombinant vector contains the chicken CX3CL1 gene, and the vector is an LV5 vector. After the chicken CX3CL1 lentiviral recombinant vector is transfected, the deposition of lipid droplets in intramuscular adipocytes is reduced.
2. The use according to claim 1, It is characterized in that The construction method of the CX3CL1 lentiviral recombinant vector is as follows: Step 1, obtaining the full-length CDS amplification product of the chicken CX3CL1 gene; Step 2, digesting the full-length CDS amplification product of the CX3CL1 gene; Step 3, digest the LV5 vector; Step 4, purifying the enzyme digestion product obtained in step 2 and the enzyme digestion product obtained in step 3 and then connecting them; Step 5, transforming the ligation product obtained in step 4 into TOP10 competent cells, sequencing and analyzing the positive clones, and the one with completely correct sequence alignment is the successfully constructed CX3CL1 gene expression vector plasmid; Step 6, ultrapurely extract the constructed CX3CL1 gene expression vector plasmid, package the extracted plasmid, co-transfect the packaging plasmid and the extracted CX3CL1 gene expression vector plasmid into cells, package and collect the lentivirus, and perform titer detection to obtain the CX3CL1 lentiviral recombinant vector.
3. The use according to claim 2, It is characterized in that The specific steps of obtaining the full-length CDS amplification product of the chicken CX3CL1 gene in step 1 are as follows: Step 1.1, design primers using oligo software according to the CX3CL1 CDS sequence. The CX3CL1 sequence is shown in SEQ ID NO.
37. The upstream and downstream primers of the CX3CL1 gene contain NotI and BamHI restriction sites and protective bases at both ends, which are used for subcloning of the vector. The primers are as follows: , , ; Step 1.2, dissolve primers Oligo-1 to Oligo-36 in ultrapure water to a concentration of 50 μM, then take the same volume to a 1.5 ml centrifuge tube, mix well, prepare oligo mix, and use the prepared oligo mix for the first round of PCR reaction; the first round of PCR reaction system is: oligo mix: 2 μl, 10×Pfu Buffer containing Mg 2+ :3µl, dNTP: 0.6µl, DMSO: 1.2µl, ddH 2 O: 23µl, Pfu DNA polymerase: 0.2µl; PCR reaction conditions: 95℃ 3min, 1 cycle; 95℃ 22sec, 58℃ 22sec, 72℃ 40sec, 22 cycles; 72°C for 5 min, 1 cycle; Step 1.3, use primers Oligo-1 and Oligo-36 for the second round of PCR reaction. The second round PCR reaction system is: first round PCR product: 1μl, 10×Pfu Buffer containing Mg 2+ :5μl, dNTP: 1μl, DMSO: 2μl, Oligo-1: 1μl, Oligo-36: 1μl, ddH 2 O: 39μl, Pfu DNA polymerase: 0.3μl; PCR reaction conditions: 95℃ 3min, 1 cycle; 95℃ 22sec, 58℃ 22sec, 72℃ 40sec, 32 cycles; 72℃ 5min, 1 cycle; after the PCR reaction, Agarose electrophoresis and gel cutting were used to recover the gene fragments.
4. The use according to claim 2, It is characterized in that The full-length CDS amplified product of the CX3CL1 gene was digested as described in step 2, specifically as follows: the full-length CDS product of the CX3CL1 gene was digested with NotI and BamHI at 37°C for 2 hours, and the digestion system was 10× Buffer: 5μl, full-length CDS product of the CX3CL1 gene: 42μl, BamHI and NotI each 1.5μl.
5. The use according to claim 2, It is characterized in that The LV5 vector was digested as described in step 3, specifically as follows: the LV5 vector was digested with NotI and BamHI at 37°C for 2 hours, the digestion system was: 10 × Buffer: 5μl, LV5: 5ug, BamHI and NotI 1.5μl each, and ultrapure water was added to 50μl.
6. The use according to claim 2, It is characterized in that The digestion product obtained in step 2 and the digestion product obtained in step 3 are purified in step 4 and then connected, specifically as follows: the full-length CDS product of the CX3CL1 gene and the vector LV5 are recovered using a DNA gel recovery kit; the double-digested CX3CL1 gene fragment and the linearized LV5 vector are connected using T4 DNA ligase, and the connection is carried out at 22° C. for 2 hours. The connection system is: T4 DNA ligase buffer: 2 μl, LV5: 2 μl, CX3CL1 gene full-length CDS product: 5 μl, T4 DNA ligase: 1 μl, ddH 2 O: 10 μl.
7. The use according to claim 2, It is characterized in that In step 5, the ligation product obtained in step 4 is transformed into TOP10 competent cells as follows: Add 10μl of the ligation product to the centrifuge tube with competent cells, mix gently, and place in ice for 30 minutes; place the centrifuge tube in a water bath preheated to 42°C and place for 90 seconds without shaking the centrifuge tube; quickly transfer the centrifuge tube to an ice bath to cool the cells for 3 minutes, add 800 µl of LB medium without antibiotics to each centrifuge tube, and then transfer the centrifuge tube to a 37°C shaker at 250 rpm and incubate for 45 minutes to allow the bacteria to recover; take 200µl of the incubated cells and evenly spread them on an LB plate containing 50µg / ml Ampicillin. After the liquid on the plate is absorbed, place the plate upside down in a 37°C incubator and incubate for 16 hours.
8. The use according to claim 2, It is characterized in that The packaging plasmids described in step 6 are pGag / Pol, pRev and pVSV-G.
9. The use according to claim 2, It is characterized in that In step 6, the packaging plasmid and the extracted CX3CL1 gene expression vector plasmid are co-transfected into cells to package and collect the lentivirus and perform titer detection, as follows: (1) When 293T cells are fused to 50-60%, the extracted CX3CL1 gene expression vector plasmid and packaging plasmid are transfected into the cells together. Take a sterile 5 mL centrifuge tube, add 1.5 mL serum-free DMEM, 3 μL of the extracted CX3CL1 gene expression vector plasmid and packaging plasmid, and mix well; take another sterile 5 mL centrifuge tube, add 1.5 mL serum-free DMEM, and then add 200 μL RNAi-Mate transfection reagent, mix well, and place at room temperature for 5 minutes. Mix the two tubes and place at room temperature for 20-25 minutes to form a transfection mixture; add the transfection mixture to the cell culture medium and incubate in a 37ºC 5% CO2 incubator for 4-6 hours; (2) Aspirate the transfection solution and add 10 mL of DMEM containing 10% FBS at 37°C and 5% CO. 2 Continue to culture in the incubator for 72 h; (3) Collect the cell supernatant in the culture dish and centrifuge at 4°C, 4000 rpm for 4 min. Filter the supernatant with a 0.45 μm filter. Ultracentrifuge the filtrate in a centrifuge at 4°C, 20,000 rpm for 2 h. Collect the concentrate and divide it into 1.5 ml centrifuge tubes and store it in a -80°C refrigerator.
Citation Information
Patent Citations
PGC-1 alpha gene overexpression lentiviral vector, PGC-1 alpha lentivirus and construction method and application
CN107245501A
